4-1BB agonism: adding the accelerator to cancer immunotherapy

by Chester, Cariad, Ambulkar, Siddhant, Kohrt, Holbrook E.
Published 2016

Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy

by Chester, Cariad, Fritsch, Katherine, Kohrt, Holbrook E.
Published 2015

Immunotherapeutic approaches to ovarian cancer treatment

by Chester, Cariad, Dorigo, Oliver, Berek, Jonathan S, Kohrt, Holbrook
Published 2015

Reovirus activated NK cells show enhanced cetuximab mediated antibody-dependent cellular cytotoxicity against colorectal cancer cells

by Zhao, Xing, Rajasekaran, Narendiran, Chester, Cariad, Yonezawa, Atsushi, Dutt, Suparna, Coffey, Matt, Kohrt, Holbrook E
Published 2015

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

by Makkouk, Amani, Sundaram, Vandana, Desai, Manisha, Chester, Cariad, Maecker, Holden, Kohrt, Holbrook E
Published 2015

Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment

by Rajasekaran, Narendiran, Chester, Cariad, Yonezawa, Atsushi, Zhao, Xing, Kohrt, Holbrook E
Published 2015

Influence of age on androgen deprivation therapy-associated Alzheimer’s disease

by Nead, Kevin T., Gaskin, Greg, Chester, Cariad, Swisher-McClure, Samuel, Dudley, Joel T., Leeper, Nicholas J., Shah, Nigam H.
Published 2016

Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade

by Mueller, Antonia MS, Hebb, Jonathan, Sagiv-Barfi, Idit, Marabelle, Aurelien, Houot, Roch, Rajapaksa, Amanda, Czerwinski, Debra K, Chang, Serena, Chester, Cariad, Sadaram, Mohith, Waller, Erin, Levy, Ronald, Kohrt, Holbrook
Published 2014